Taiji Group

Taiji Group is a prominent Chinese pharmaceutical conglomerate headquartered in Chongqing and currently operates as a key subsidiary of Sinopharm (China National Pharmaceutical Group). The company specializes in the research, development, and manufacturing of both Traditional Chinese Medicine (TCM) and Western chemical pharmaceuticals. It holds a dominant market position in China with flagship products like Huoxiang Zhengqi Oral Liquid, which is widely used for respiratory and digestive ailments. Taiji Group maintains a vast industrial chain including large-scale GMP manufacturing bases, medicinal herb cultivation sites, and an extensive retail pharmacy network. Following its integration into Sinopharm in 2021, the company has accelerated its digital transformation and focus on high-end generics and innovative biological drugs. It remains a pivotal entity in the modernization and globalization of Chinese pharmaceutical products.